HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changwei Dou Selected Research

p300-CBP-associated factor

1/2018P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
5/2016PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Changwei Dou Research Topics

Disease

21Neoplasms (Cancer)
10/2020 - 11/2014
18Hepatocellular Carcinoma (Hepatoma)
03/2021 - 11/2014
10Neoplasm Metastasis (Metastasis)
03/2021 - 12/2014
3Hemorrhage
01/2022 - 01/2020
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 02/2015
2Breast Neoplasms (Breast Cancer)
03/2021 - 12/2016
2Cholangiocarcinoma
11/2020 - 10/2020
2Lung Neoplasms (Lung Cancer)
01/2020 - 02/2019
2Hypoxia (Hypoxemia)
01/2019 - 01/2017
2Glioma (Gliomas)
11/2018 - 05/2016
1Infections
10/2020
1Abdominal Abscess
10/2020
1Liver Failure
10/2020
1Wound Infection (Wound Infections)
10/2020
1Gallbladder Neoplasms (Gallbladder Cancer)
01/2020
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Intestinal Neoplasms (Intestinal Cancer)
02/2019
1Ovarian Neoplasms (Ovarian Cancer)
02/2019
1Colonic Neoplasms (Colon Cancer)
01/2018
1Thrombosis (Thrombus)
12/2017
1Fibrosis (Cirrhosis)
01/2017
1Carcinogenesis
01/2017
1Lymphoma (Lymphomas)
12/2016
1Inflammation (Inflammations)
10/2015
1Carcinoma (Carcinomatosis)
05/2015
1Portal Hypertension
02/2015

Drug/Important Bio-Agent (IBA)

6MicroRNAs (MicroRNA)IBA
01/2019 - 11/2014
5Biomarkers (Surrogate Marker)IBA
03/2021 - 12/2014
5Proteins (Proteins, Gene)FDA Link
03/2021 - 02/2016
4Biological ProductsIBA
03/2021 - 04/2016
3Small Interfering RNA (siRNA)IBA
10/2019 - 02/2015
2Transcription Factors (Transcription Factor)IBA
10/2019 - 05/2016
2Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2018 - 05/2016
2p300-CBP-associated factorIBA
01/2018 - 05/2016
2Messenger RNA (mRNA)IBA
01/2017 - 04/2016
2Long Noncoding RNAIBA
01/2017 - 08/2016
2HMGB1 Protein (HMG1)IBA
06/2016 - 10/2015
2Indicators and Reagents (Reagents)IBA
06/2016 - 05/2015
1hydroxide ionIBA
10/2020
1Connective Tissue Growth FactorIBA
10/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2019
1TenascinIBA
10/2019
1PeriostinIBA
10/2019
1Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA
10/2019
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2019
1platelet-derived growth factor C (PDGF-C)IBA
10/2019
1Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA
02/2019
1ChromatinIBA
01/2019
1Fluorouracil (Carac)FDA LinkGeneric
01/2019
1Protein HydrolysatesFDA Link
11/2018
1Oviductus RanaeIBA
11/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1Conditioned Culture MediaIBA
01/2018
1Serine (L-Serine)FDA Link
01/2018
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2017
1Pyruvate KinaseIBA
12/2017
1SirtuinsIBA
11/2017
1Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
11/2017
1NADP (NADPH)IBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1sphingosine kinaseIBA
01/2017
1EnzymesIBA
01/2017
1Dynamin IIIBA
01/2017
1NADPH Oxidase 4IBA
01/2017
1tyrosine receptor (receptor, tyrosine)IBA
01/2017
1lymphocyte-specific protein p50IBA
12/2016
1Untranslated RNA (Noncoding RNA)IBA
05/2016
1B-Cell Lymphoma 3 ProteinIBA
04/2016
1Cyclin D1IBA
04/2016
1Cadherins (E-Cadherin)IBA
02/2016
1Tissue Inhibitor of Metalloproteinase-1IBA
05/2015
1C-terminal binding proteinIBA
02/2015
1Co-Repressor ProteinsIBA
02/2015
1Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2014
1PPAR gammaIBA
11/2014

Therapy/Procedure

3Length of Stay
01/2022 - 01/2020
2Lymph Node Excision (Lymph Node Dissection)
11/2020 - 10/2020
1Hepatectomy
10/2020
1Laparotomy
01/2020
1Drug Therapy (Chemotherapy)
01/2019
1Subcutaneous Injections
01/2018
1Intraperitoneal Injections
01/2018
1Splenectomy
02/2015